| 000 | 01828 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514162648.0 | ||
| 264 | 0 | _c20040223 | |
| 008 | 200402s 0 0 spa d | ||
| 022 | _a0002-5151 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodrÃguez Orozco, Alain R | |
| 245 | 0 | 0 |
_a[Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency]. _h[electronic resource] |
| 260 |
_bRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) _c |
||
| 300 |
_a198-200 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aBromocriptine _xtherapeutic use |
| 650 | 0 | 4 |
_aCommon Variable Immunodeficiency _xcomplications |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperprolactinemia _xcomplications |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 650 | 0 | 4 |
_aOmeprazole _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPyrrolidonecarboxylic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aRabeprazole |
| 650 | 0 | 4 |
_aRanitidine _xtherapeutic use |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aThiazoles _xtherapeutic use |
| 650 | 0 | 4 | _aThiazolidines |
| 650 | 0 | 4 |
_aTransfer Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aVitamins _xtherapeutic use |
| 650 | 0 | 4 |
_agamma-Globulins _xtherapeutic use |
| 773 | 0 |
_tRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) _gvol. 50 _gno. 5 _gp. 198-200 |
|
| 999 |
_c14367902 _d14367902 |
||